Keith Humphreys

Keith Humphreys

Stanford University

H-index: 83

North America-United States

About Keith Humphreys

Keith Humphreys, With an exceptional h-index of 83 and a recent h-index of 44 (since 2020), a distinguished researcher at Stanford University,

His recent articles reflect a diverse array of research interests and contributions to the field:

A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder

Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment?

A Randomized Controlled Trial of a Pay-for-Performance Initiative to Reduce Costs of Care for High-Need Psychiatric Patients

Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed US regulatory relaxations: a model-based analysis

Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the OHDSI network

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Long-term effects of increasing buprenorphine treatment seeking, duration, and capacity on opioid overdose fatalities: a model-based analysis

Clinical research: The samples are narrow, but at least the conclusions are broad

Keith Humphreys Information

University

Position

Esther Ting Memorial Professor

Citations(all)

21728

Citations(since 2020)

8155

Cited By

16545

hIndex(all)

83

hIndex(since 2020)

44

i10Index(all)

251

i10Index(since 2020)

148

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Top articles of Keith Humphreys

Title

Journal

Author(s)

Publication Date

A pilot, randomized clinical trial: Left dorsolateral prefrontal cortex intermittent theta burst stimulation improves treatment outcomes in veterans with alcohol use disorder

Alcohol: Clinical and Experimental Research

Claudia B Padula

Daniel M McCalley

Lea‐Tereza Tenekedjieva

Kelly MacNiven

Andrew Rauch

...

2024/1

Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment?

Drug and Alcohol Review

Emmert Roberts

Keith Humphreys

2024/1

A Randomized Controlled Trial of a Pay-for-Performance Initiative to Reduce Costs of Care for High-Need Psychiatric Patients

Psychiatric Services

Daniel M Blonigen

Keith Humphreys

2024/4/3

Estimated effectiveness and cost-effectiveness of opioid use disorder treatment under proposed US regulatory relaxations: a model-based analysis

Current Developments in Nutrition

Stephen Vosti

Reina Engle-Stone

Demewoz Woldegebreal

Hanqi Luo

Elias Asfaw

...

2020/6/1

Towards global model generalizability: independent cross-site feature evaluation for patient-level risk prediction models using the OHDSI network

Journal of the American Medical Informatics Association

Behzad Naderalvojoud

Catherine M Curtin

Chen Yanover

Tal El-Hay

Byungjin Choi

...

2024/2/27

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

Addiction Science & Clinical Practice

RR Cook

C Foot

OA Arah

K Humphreys

KE Rudolph

...

2023/2/14

Long-term effects of increasing buprenorphine treatment seeking, duration, and capacity on opioid overdose fatalities: a model-based analysis

Journal of addiction medicine

Erin J Stringfellow

Tse Yang Lim

Catherine DiGennaro

Ziyuan Zhang

Pritika Paramasivam

...

2023/7/1

Clinical research: The samples are narrow, but at least the conclusions are broad

Journal of General Internal Medicine

Keith Humphreys

2023/9

Healthcare costs and use before and after opioid overdose in Veterans Health Administration patients with opioid use disorder

Addiction

Vilija R Joyce

Elizabeth M Oliva

Carla C Garcia

Jodie Trafton

Steven M Asch

...

2023/11

Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder

Drug and alcohol dependence

Gary Qian

Isabelle Rao

Keith Humphreys

Douglas K Owens

Margaret L Brandeau

2023/2/1

Adapting a Telephone-Based, Dyadic Self-management Program to Be Delivered Over the Web: Methodology and Usability Testing

JMIR Formative Research

Ranak Trivedi

Sierra Kawena Hirayama

Rashmi Risbud

Madhuvanthi Suresh

Marika Blair Humber

...

2023/6/16

Analysing the use trends of new psychoactive substances using wastewater-based epidemiology in Europe: A systematic review

Gabriel Gatica-Bahamonde

Elizabeth Alexandra Godynyuk

Jessica Neicun

Emmert Roberts

Mehmet Mikail Tangerli

...

2023/8/21

Leadership Styles Experienced During Military Service Predict Later Anhedonic Depressive Symptoms and Self-Efficacy in Veterans With Alcohol Use Disorder

Military Medicine

Timothy C Durazzo

Keith Humphreys

Michael A LaRocca

2023/10/28

State cannabis legalization and psychosis-related health care utilization

JAMA network open

Holly Elser

Keith Humphreys

Mathew V Kiang

Swapnil Mehta

Jong H Yoon

...

2023/1/3

The evolution of telepsychiatry for substance use disorders during COVID-19: a narrative review

Noam Fast

Robin van Kessel

Keith Humphreys

Natalie Frances Ward

Andres Roman-Urrestarazu

2023/6

Prediction of opioid-related outcomes in a medicaid surgical population: Evidence to guide postoperative opiate therapy and monitoring

PLoS Computational Biology

Oualid El Hajouji

Ran S Sun

Alban Zammit

Keith Humphreys

Steven M Asch

...

2023/8/14

A practical strategy for increasing representation of women in research

bmj

Keith Humphreys

2023/10/17

Drug-related deaths among housed and homeless individuals in the UK and the USA: comparative retrospective cohort study

The British Journal of Psychiatry

Emmert Roberts

Caroline Copeland

Keith Humphreys

Chelsea L Shover

2023/12

Predicting premature discontinuation of medication for opioid use disorder from electronic medical records

AMIA Annual Symposium Proceedings

Ivan Lopez

Sajjad Fouladvand

Scott Kollins

Chwen-Yuen Angie Chen

Jeremiah Bertz

...

2023

Cost-effectiveness of increasing buprenorphine treatment initiation, duration, and capacity among individuals who use opioids

JAMA Health Forum

Anneke L Claypool

Catherine DiGennaro

W Alton Russell

Melike F Yildirim

Alan F Zhang

...

2023/5/5

See List of Professors in Keith Humphreys University(Stanford University)